Healthcare & Life Sciences

Cell-Easy

France
aliveseries-a
series-a
Stage

About

Cell-Easy is a contract development and manufacturing organization (CDMO) that produces ready-to-inject adipose-derived allogeneic stem cell products under cGMP conditions, supporting preclinical and clinical drug development with regulatory-compliant, scalable supply inspected by the French ANSM.

Explore Cell-Easy's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.